BMCS BioTech Medics Inc (PK)

BioTech Medics, Inc. (PINKSHEETS: BMCS) announced today that they have begun the pre-production stage of creating two minute, sixty second and thirty second direct response TV and radio commercials for nationwide distribution for its proprietary SHBAN™ Alcohol Free Antiseptic Hand Sanitizer. This is to create brand awareness and sales.

BioTech has retained former Miss Arizona (1989) and Miss USA Top 10 Finalist LeeAnne Lochen. Ms. Lochen co-starred with Golden Globe actress Susan Bullock in "Miss Congeniality" as "Miss Nebraska" in the 2000 movie. She also has appeared in "Walker Texas Ranger," "Inspector Mom" and numerous TV commercials including one which won an award on ABC's "Americas Funniest Commercials."

BioTech will be offering a SHBAN Alcohol Free Hand Sanitizer Multiuse Package.

SHBAN has been tested extensively for over 12 years. Its active ingredient is FDA approved. SHBAN was invented by Edward J. Cragoe, Jr. PhD. who has invented over 19 drugs in his career. SHBAN has been independently clinically proven to kill the H1N1 (Swine) Influenza A virus.

SHBAN in previous in vitro and in vivo testing has been evaluated for its antimicrobial properties against MRSA, Staph. Aureus, Staph. Epidermidis, EC. Faecalis, E. Coli and Ps. Aeruginosa.

SHBAN is a bio-degradable product superior to most anti-bacterial antiseptics because 1) SHBAN is longer lasting. SHBAN does not evaporate within 15 seconds after application and cease working (like alcohol gels); 2) SHBAN is non-toxic when used as directed on humans and animals (over 22,000 alcohol poisoning calls have been placed to the Poison Control Center within the past 3 years); 3) SHBAN is non-staining, non-bleaching; 4) SHBAN is non-flammable and 5) SHBAN has no harmful or toxic odors. Most hand sanitizer products cannot make all of these claims.

SHBAN is protected under US Letters of Patent #5,514,808, #5,574,050, #5,679,711 and #5,585,391 and pending international patent. SHBAN is a trademark of BioTech Medics, Inc. BioTech is negotiating USA and foreign distributorships at this time.

Safe Harbor: Forward-Looking Statements

This release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). The SHBAN statements above have not been evaluated by the FDA. SHBAN is not intended to diagnose, treat or cure any disease.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact: Keith Houser CEO Phone: 972-274-5533